A landing zone in OneLake stores both the snapshot and change data, to improve performance when converting files into delta verti-parquet. Yes. If your Azure SQL Managed Instance is not publicly ...

Azure SQL Managed Instance gains SQL Server 2025 update policy control. GA policy balances new engine features with operational stability governance. Enhanced update management supports enterprise ...

DBeaver is a free, open-source, cross-platform SQL client and database administration tool. It is designed to support a wide variety of SQL and NoSQL databases, including MySQL and PostgreSQL. Its key ...

Amid the AI-heavy headlines at Microsoft's annual conference, several behind-the-scenes updates landed that could have a major impact on how IT teams build, run and scale core infrastructure in Azure.

Organizations are under constant pressure to modernize their estate. Legacy infrastructure, manual processes, and increasing data volumes in silos make it harder to deliver the performance, security, ...

Managing SQL Server across hybrid and multi-cloud environments has long posed a challenge for database administrators. With data sprawled across on-premises infrastructure, cloud platforms, and edge ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Andy Brinkmeyer shares how engineering ...

Starting in October, Microsoft will enforce multi-factor authentication (MFA) for all Azure resource management actions to protect Azure clients from unauthorized access attempts. This change is part ...

Microsoft has launched Azure Arc-enabled SQL Server on Windows in the US Government, Virginia region. The Redmond giant called this a "major first step". Microsoft has recently announced that Azure ...

We’re excited to announce a new migration capability in Azure Arc to simplify and accelerate SQL Server migration. This new capability, now generally available, is powered by Azure Database Migration ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...